Literature DB >> 22307444

Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease.

Giovanni Abbruzzese1, Angelo Antonini, Paolo Barone, Fabrizio Stocchi, Tiziano Tamburini, Laura Bernardi, Marianna Amboni, Laura Vacca, Valeria Posocco, Delia Colombo.   

Abstract

A patient self-rated 19-item wearing-off questionnaire (WOQ-19) was shown to be a potent screening tool for wearing-off (WO) in patients with Parkinson's disease. As part of the early detection of wearing-off in Parkinson's disease study, we preliminarily performed a linguistic and a psychometric validation of an Italian version of the WOQ-19. Moreover, we assessed the sensitivity and specificity of the WOQ-19 in the office-based settings. The psychometric validation study included assessment of discriminant ability, internal consistency and test-retest reliability. The intraclass correlation coefficient (ICC) and the Cronbach's Alpha were assessed. The WOQ-19 sensitivity and specificity were calculated in respect to the physician assessment of WO, taken as the gold standard. The Italian version of WOQ-19 was found easy to understand by ≥ 80% of the patients. The number of WO-related symptoms detected by WOQ-19 was 7.5 ± 3.2 in patients with WO and 1.6 ± 2.6 in patients without WO (p < 0.0001). Cronbach's alpha was equal to 0.868 for the total number of WO symptoms. The ICC value was equal to 0.858 for WO-related symptoms as a whole. The diagnostic ability study recruited 207 patients: for a WOQ-19 cut-off ≥ 2, the sensitivity was equal to 0.881 and the specificity was 0.674. This is the first validation of WOQ-19 in Italian, with excellent linguistic validity and psychometric properties. WOQ-19 was confirmed to be reliable in WO detection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307444     DOI: 10.1007/s10072-012-0943-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

1.  Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.

Authors:  A Schrag; N Quinn
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

Review 2.  Levodopa in the treatment of Parkinson's disease: current controversies.

Authors:  C Warren Olanow; Yves Agid; Yoshi Mizuno; Alberto Albanese; Ubaldo Bonuccelli; U Bonucelli; Philip Damier; Justo De Yebenes; Oscar Gershanik; Mark Guttman; F Grandas; Mark Hallett; Ole Hornykiewicz; Peter Jenner; R Katzenschlager; William J Langston; Peter LeWitt; Eldad Melamed; M A Mena; P P Michel; Catherine Mytilineou; Jose A Obeso; Werner Poewe; Niall Quinn; R Raisman-Vozari; Ali H Rajput; Olivier Rascol; Christina Sampaio; Fabrizio Stocchi
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

Review 3.  Wearing-off scales in Parkinson's disease: critique and recommendations.

Authors:  Angelo Antonini; Pablo Martinez-Martin; Ray K Chaudhuri; Marcelo Merello; Robert Hauser; Regina Katzenschlager; Per Odin; Mark Stacy; Fabrizio Stocchi; Werner Poewe; Oliver Rascol; Cristina Sampaio; Anette Schrag; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2011-07-20       Impact factor: 10.338

4.  Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

Authors: 
Journal:  JAMA       Date:  2000-10-18       Impact factor: 56.272

5.  Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.

Authors:  Patrick Santens; Alain Maertens de Noordhout
Journal:  Acta Neurol Belg       Date:  2006-09       Impact factor: 2.396

6.  Nonmotor fluctuations in Parkinson's disease: frequent and disabling.

Authors:  Tatiana Witjas; E Kaphan; J P Azulay; O Blin; M Ceccaldi; J Pouget; M Poncet; A Ali Chérif
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

7.  Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.

Authors: 
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

8.  [Precoce survey: a new self-assessment patient card for early detection and management of Parkinson disease fluctuations].

Authors:  J-P Azulay; F Durif; R Rogez; C Tranchant; I Bourdeix; K Rerat
Journal:  Rev Neurol (Paris)       Date:  2008-04-03       Impact factor: 2.607

Review 9.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

10.  Validation of the "QUICK" questionnaire--a tool for diagnosis of "wearing-off" in patients with Parkinson's disease.

Authors:  Pablo Martinez-Martin; Eduardo Tolosa; Basilio Hernandez; Xavier Badia
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

View more
  6 in total

1.  Gait analysis and clinical correlations in early Parkinson's disease.

Authors:  M Pistacchi; M Gioulis; F Sanson; E De Giovannini; G Filippi; F Rossetto; S Zambito Marsala
Journal:  Funct Neurol       Date:  2017 Jan/Mar

2.  The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study.

Authors:  Delia Colombo; Giovanni Abbruzzese; Angelo Antonini; Paolo Barone; Gilberto Bellia; Flavia Franconi; Lucia Simoni; Mahmood Attar; Emanuela Zagni; Shalom Haggiag; Fabrizio Stocchi
Journal:  ScientificWorldJournal       Date:  2015-01-20

Review 3.  Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review.

Authors:  Carlos E Mantese; Artur Schumacher-Schuh; Carlos R M Rieder
Journal:  Parkinsons Dis       Date:  2018-04-01

4.  Validating the Vietnamese version of wearing - Off 19 questionnaire for patients with Parkinson's disease.

Authors:  Uyen Le Ngoc Ha; Tai Ngoc Tran; Minh Le; Thuong Huyen Thi Dang; Nhi Anh Vũ; Daniel Truong
Journal:  Clin Park Relat Disord       Date:  2019-08-05

5.  Gender differences in the adverse events' profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis.

Authors:  Delia Colombo; Emanuela Zagni; Mihaela Nica; Sara Rizzoli; Alessandra Ori; Gilberto Bellia
Journal:  Drug Des Devel Ther       Date:  2016-09-13       Impact factor: 4.162

6.  Philippine translation and validation of the Wearing-off Questionnaire-19.

Authors:  Katrina C Remigio; Roland Dominic G Jamora
Journal:  Clin Park Relat Disord       Date:  2019-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.